NICE NG238: cardiovascular disease risk assessment and reduction, including lipid modification
The UK NICE guideline NG238 on assessing and reducing the risk of cardiovascular disease, including lipid modification. Only an NCBI Bookshelf catalogue record was read, so this page gives no recommendations.
- Guideline
- In this atlas
Overview
Technical summary
NCBI Bookshelf lists NG238 with a publisher line dated 2023 Dec 14 (series statement NICE Clinical Guidelines, No. 238). That is the date of the Bookshelf copy; the NICE publication and update dates were not read because nice.org.uk was not fetched. NICE content is cite only, so this atlas states what it read in its own words.
About this guideline
- Status
- Not checked for a newer edition
Source
- Document
- Cardiovascular disease: risk assessment and reduction, including lipid modification (NICE guideline NG238)
- Publisher
- National Institute for Health and Care Excellence (NICE)
- Edition note
- NCBI Bookshelf catalogue record for NG238, dated 2023 Dec 14 (series statement NICE Clinical Guidelines, No. 238). The link goes to the NICE page, which was not fetched. The Bookshelf date is the date of that copy, not necessarily of the NICE publication or last update.
Recommendations
No recommendation in this atlas names this guideline yet.
Record details
- Record id
cardio:guideline-nice-ng238- Content hash
fa32e912733c79921fcf8123cb42d73c86aa7f5b9791569842f9ab7cd984ef8a